Ashraf A. Tabll - Concepedia

Author

Ashraf A. Tabll

Also Known As

A Tabll, A. A. Tabll, A. Tabll, A.A. Tabll, A.A. Tabll ., Ashraf A Tabll, Ashraf A. Tabll, Ashraf A. Tabll ., Ashraf Abdou Tabll, Ashraf Tabll

117

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National Research Centre Mansoura University Damietta University Cairo University National Water Research Center

About

Ashraf A. Tabll is an author at National Research Centre specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	390
2	Health Sciences	3	3	91
3	Education	1	1	14
4	Natural Sciences	1	1	19
5	Biomolecular Engineering	1	1	13

Ashraf A. Tabll

Publications

962

Citations

H-Index

Page 1

	Year	Citations
Camel Lactoferrin Markedly Inhibits Hepatitis C Virus Genotype 4 Infection of Human Peripheral Blood Leukocytes Elrashdy M. Redwan, Ashraf A. Tabll Journal of Immunoassay and Immunochemistry	2007	130
Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease Mostafa K. El Awady, Lotiaf Mostafa, Ashraf A. Tabll, Hepatitis Monthly	2012	57
HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. Mostafa K. El Awady, Ashraf A. Tabll, Yasmine S. El, PubMed	2006	52
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy Mostafa K. El Awady, Mohamed A. Anany, Gamal Esmat, Journal of Gastroenterology and Hepatology	2010	50
Detection of serum p53 protein in patients with different gastrointestinal cancers Abdelfattah M. Attallah, Mohamed Mohamed Abdel-Aziz, Amina Mohamed El-Sayed, Cancer Detection and Prevention Serum P53 ProteinOncologyGastrointestinal OncologyCancer DetectionMedicine	2003	48
Potential Activity of Camel Milk-Amylase and Lactoferrin against Hepatitis C Virus Infectivity in HepG2 and Lymphocytes Esmail M. El‐Fakharany, Ashraf A. Tabll, Abeer Abd El-W Wahab, Potential ActivityImmunologyCamel Milk-amylaseAntiviral DrugViral Hepatitis	2008	47
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs Shadia A. Galal, Ahmed S. Abdelsamie, Samia A. Shouman, European Journal of Medicinal Chemistry Drug TargetHealth SciencesCheckpoint Kinase 2Genotoxic DrugsMedicine	2017	43
Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry. Mostafa K. El Awady, Ashraf A. Tabll, Elrashdy M. Redwan, PubMed	2005	35
Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease Mostafa K. El Awady, Lotiaf Mostafa, Ashraf A. Tabll, Hepatitis Monthly Healthy SubjectsGenetic EpidemiologyImmunologyHepatitis BImmune-related Gene Polymorphism	2012	35
Human cytomegalovirus infection inhibits response of chronic hepatitis‐C‐virus‐infected patients to interferon‐based therapy Noha G. Bader El Din, Mai Abd El-Meguid, Ashraf A. Tabll, Journal of Gastroenterology and Hepatology	2010	34

Page 1